A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Voice Worries
However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users administering substances of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, marketing, and customer laws, potentially leading to penalties, prosecution or prison.
Platform Response and Content Removal
According to the social media company, the platform has removed violative material and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the service safe and investing in enhancing enforcement strategies.
Online Trading Operations
Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.
Within moments of joining one community, a seller posted contact information, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages display dark colored parcels with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly serious medical dangers”.
